Status:
RECRUITING
Primary and Secondary Elevations of Maxillary Sinuses: a Prospective Clinical Study in the Posterior Maxillary Region
Lead Sponsor:
Nanfang Hospital, Southern Medical University
Conditions:
Tooth Loss
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
About 40 people will participate in the study, which will be conducted at Southern Medical University Southern Hospital. All subjects need to sign an informed consent form before screening, and succes...
Eligibility Criteria
Inclusion
- Age≥ 18 years old
- If the posterior maxillary tooth is missing for ≥ 3 months, the patient requires implant restoration and the preoperative examination meets the indications for intramaxillary sinus lift
- Can be scanned with radiology equipment before and after surgery
- RBH ≤ 5mm, alveolar ridge width ≥5mm, each implant site is measured on CBCT
- During implant healing, there is no removable restoration at the implant site
- No history of acute or chronic sinusitis disease, no history of maxillary sinus disease, and no history of previous maxillary sinus surgery
- Be willing to sign informed consent and authorization form, and be able to return to the clinic on time
Exclusion
- Heavy smokers (10 cigarettes smoked ≥ day)
- Uncontrolled diabetes (glycated hemoglobin \>7%), metabolic bone disease, autoimmune disease or other systemic diseases, the body can hardly withstand implant surgery
- Mentally unable, pregnant or pregnant women
- Any history of contraindications or significant impact on dental implant placement, such as bisphosphonate drug use, chemotherapy or immunosuppressants, head and neck radiotherapy, autoimmune disease, and hypertension
- Untreated periodontal disease, endodontics, or other oral diseases
- Bruxism patients
- Previous implant implant failure at the surgical site
- Anatomical changes in the maxillary sinus, such as maxillary sinus septum or mucosal swelling (defined as the mean thickness of the Schneider membrane at the base of the maxillary sinus \> 2 mm)
Key Trial Info
Start Date :
April 7 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06106321
Start Date
April 7 2024
End Date
December 1 2025
Last Update
April 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NanFang Hospital of Sourthern Medical University
Guangzhou, Guangdong, China